Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The last word, again
View:
Post by N0taP00p on Jan 14, 2025 3:49pm

The last word, again

What matters is BTD in Q1. Everything else is a distraction. We're circling the drain, yet THIS close.  C'mon FDA. Give TLT a break. At least, give our Thera-hustlers a break. It's hard to generate hot air 24x7.  We need that BTD now.
Comment by Legit62 on Jan 14, 2025 4:25pm
One thing is for sure ,if we do not receive BTD we all know the FDA fix was in, with the positive data we have presented,better than anything out there, with the positive safety , with the extended CRs , lets get this done please 
Comment by bmk211 on Jan 14, 2025 4:56pm
You read my mind!
Comment by chry200030 on Jan 14, 2025 6:26pm
Q1 ends March 31. Let's be patient a bit..
Comment by Johnandrose22 on Jan 14, 2025 6:58pm
Thanks, chry200030...that's a prudent point to make..."the company plans to compile a BTD submission for review by the FDA in 1Q2025 in support of the grant of a BTD approval"....That is a 90 day window to achieve the company's goal of submitting an application....Deep breath....Let's not take out the verbal guillotine just yet....as some on this board would strategically ...more